Health and Healthcare
49 Articles
Teva Pharmaceutical resume a deal-making strategy that made it one of the most acquisitive drug companies of the past decade.…
The analysts at UBS are not only bullish on the biotechnology sector, they think there is a very distinct possibility…
Finviz.comWith the end of the year two weeks away, 10 stocks have already had gains of more than 400%. Investors in…
ThinkstockEven though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive…
Our top personal finance-related articles today. Your wallet will thank you later.